Outsourcing Pharma

SEPTEMBER 19, 2023

UK-based Pharmanovia has just announced it has taken over 11 of Sanofiâs central nervous system (CNS) brands.

Branding 90

Branding Regulation Marketing 90

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Is there legacy branding? Virtual connections. Do they have the right tone?

Regulation 97

Regulation Marketing Sales Branding 97

World of DTC Marketing

FEBRUARY 1, 2021

SUMMARY: Digital ad spend in pharmaceutical brands is up 111% so far in 2020 and 80% of that money is being thrown away by fraud and the popularity of programmatic advertising. While popular, digital advertising wasn’t an immediate hit in the pharmaceuticals arena due to the strict regulations. A Waste of money?

Branding 187

Branding Regulation Marketing Research 187

Pharma Marketing Network

APRIL 11, 2025

In a highly regulated industry like pharmaceuticals, standing out online can feel like navigating a maze. Unlike retail or tech brands, pharma companies must balance compliance with creativity while communicating with multiple audiences. But what works in pharma is different from what works in other industries.

Marketing 52

Marketing Branding Regulation Production 52

Pharma Marketing Network

APRIL 10, 2025

Gone are the days when print ads and in-person detailing alone could carry a brand. In a heavily regulated industry like pharmaceuticals, PPC also offers better control than other channels. In a heavily regulated industry like pharmaceuticals, PPC also offers better control than other channels.

Marketing 52

Marketing Branding Compliance Pharma Companies 52

Pharma Marketing Network

MARCH 26, 2025

However, in a tightly regulated industry like pharmaceuticals, every message, medium, and model must adhere to strict legal and ethical standards. Misinformation and Hallucinations : Generative AI platforms may create content that is inaccurate, outdated, or off-labelviolating FDA regulations. This content is not medical advice.

Compliance 64

Compliance Marketing Regulation Pharma Companies 64

Pharma Marketing Network

OCTOBER 29, 2024

With digital channels, evolving regulations, and changing patient expectations, creating an impactful advertising strategy can feel complex. In this article, we’ll explore key pharma advertising strategies that resonate with your audience, enhance brand engagement, and help you stay ahead in a competitive industry.

Branding 52

Branding Compliance Regulation Marketing 52

Pharma Marketing Network

OCTOBER 3, 2024

In the competitive landscape of the pharmaceutical industry, effective marketing strategies are crucial for brand success. The pharmaceutical industry is characterized by intense competition, with numerous brands vying for the attention of healthcare professionals and patients.

Branding 52

Branding Marketing Compliance Regulation 52

Drug Patent Watch

FEBRUARY 19, 2025

These dedicated individuals play a critical role in ensuring that generic drugs meet the same high standards as their brand-name counterparts. Quality Assurance is a team effort : From manufacturers to regulators, QA professionals, and beyond, everyone plays a critical role in ensuring the quality and safety of generic drugs.

Generic Drugs 92

Generic Drugs Drugs Contamination Manufacturing 92

BioSpace

OCTOBER 23, 2023

The regulator has approved the first-ever subcutaneous version of infliximab, an IgG1 monoclonal antibody, commonly sold by Johnson & Johnson under the brand name Remicade.

FDA Approval 98

FDA Approval Branding Antibody Regulation 98

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays fast-evolving digital landscape, programmatic display ads are transforming the way pharma brands reach healthcare professionals (HCPs), patients, and stakeholders. But how can pharma brands leverage programmatic display ads effectively while staying compliant with strict industry regulations? The result?

Branding 52

Branding Compliance Marketing Regulation 52

Pharmaceutical Technology

FEBRUARY 24, 2023

A leaked draft (see below) of the legislation, whose final version will be published next month, proposes reducing market exclusivity time by one year for most branded drugs, although it would extend exclusivity for certain drugs for unmet needs. If you measure everything on faster, I’m not sure Europe will always come out ahead.”

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

World of DTC Marketing

JUNE 22, 2022

The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Generic drugs versus branded is also a considerable expense. Google launched itself into the wearables business in 2019 with a $2.1bn acquisition of Fitbit.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

Drug Patent Watch

MARCH 26, 2025

Generic drugs have long been a vital part of this equation, offering a more accessible alternative to brand-name medications. By working closely with partners and regulators, generic drug developers can identify potential issues early on and work together to find solutions. Share your experiences with us in the comments below!

Generic Drugs 52

Generic Drugs Compliance Development Drugs 52

Pharma Mirror

SEPTEMBER 6, 2023

by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why.

Life Science 130

Life Science Marketing Compliance Branding 130

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays digital-first world, content marketing campaigns are no longer optional for pharmaceutical brands. Imagine content marketing as the heartbeat of a pharma brands digital presence. Instead of traditional promotional tactics, pharma brands can use educational content to build credibility.

Branding 52

Branding Marketing Compliance Pharma Companies 52

Pharma Marketing Network

OCTOBER 7, 2024

In the fiercely competitive pharmaceutical industry, effective brand positioning is crucial for marketers striving to distinguish their products and services. With an ever-evolving market landscape, pharmaceutical companies must develop robust strategies to position their brands distinctively.

Branding 52

Branding Marketing Production Compliance 52

World of DTC Marketing

FEBRUARY 19, 2021

SUMMARY: More than 42,000 programmatic ads from 4,315 brands are running on websites spouting misinformation about the vaccine and COVID over the past year. Brands don’t often have power over where their programmatic ads are appearing online, due to third-party vendors. When will pharma stop using programmatic online ads?

Vaccination 180

Vaccination Vaccine Branding Regulation 180

Pharmaceutical Technology

JULY 25, 2022

Unlike biosimilars, it is simpler for small molecule specialty generics to establish equivalence to their branded forms, explains Vasquez. Watanabe refers to the example of Teva’s immunomodulator drug Copaxone used for the treatment of multiple sclerosis, which the company produced and marketed as its own branded product.

Drugs 298

Drugs Manufacturing Production Marketing 298

Pharma Marketing Network

MARCH 6, 2025

Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers.

Compliance 52

Compliance Branding Marketing Regulation 52

Pharma Marketing Network

DECEMBER 31, 2024

Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. Collaborating with them can enhance credibility and reach.

Marketing 52

Marketing Branding Compliance Drugs 52

World of DTC Marketing

FEBRUARY 7, 2022

The FTC, an antitrust regulator, has requested documents related to a civil investigative demand, similar to a subpoena, on the marketing and approval of the Alzheimer’s drug.” Biogen used to be known as an innovative Biotech company; now, their brand is associated with misinformation and desperation.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

Pharma Marketing Network

OCTOBER 8, 2024

In an ever-evolving industry like healthcare, building a robust brand strategy is no longer optional but essential for pharma marketers. The dynamic landscape demands a comprehensive approach that not only elevates brand visibility but also fosters trust and credibility among consumers.

Branding 52

Branding Marketing Development Production 52

XTalks

MARCH 26, 2025

This enhances brand recognition while also attracting new clients, strategic partners and speaking opportunities that further solidify their leadership. Our Thought Leadership Checklist outlines the essential steps to position your brand as an authority in clinical research. Will your business be one of them?

Clinical Research 52

Clinical Research Research Branding Clinical Trials 52

XTalks

JUNE 3, 2024

Its branding and marketing strategies have resonated well with younger, health-conscious consumers. The Brewing Controversy US Regulations Around Hemp The regulatory landscape for hemp in the US is complex and continually evolving. State regulations also play a significant role in the hemp beverage market. percent THC.

Regulation 52

Regulation Marketing Production Protein 52

World of DTC Marketing

MARCH 6, 2022

The excitement about these technologies partially stems from their potential to address health care system challenges that have slightly improved with traditional health care processes, payment models, regulations, guidelines, and innovations such as drugs and devices.

Production 244

Production Doctors Doctor Branding 244

STAT News

MARCH 16, 2023

regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over a recent 15-year period, but a new study found that generic companies have only twice successfully pursued an established pathway to create lower-cost, rival products.

Generic Drugs 105

Generic Drugs Branding Regulation Manufacturing 105

World of DTC Marketing

AUGUST 12, 2022

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston.

Drugs 255

Drugs Research Development Regulation 255

Drug Patent Watch

JANUARY 14, 2025

Why Generic Drugs Matter Generic drugs are the Robin Hoods of the pharmaceutical world, stealing from the rich (brand-name drugs) and giving to the poor (our wallets). They offer the same therapeutic benefits as their brand-name counterparts but at a fraction of the cost. But how do companies develop these cost-effective alternatives?

Generic Drugs 86

Generic Drugs Development Drugs Manufacturing 86

Pharma Marketing Network

NOVEMBER 20, 2024

With its ability to combine visuals, messaging, and precise targeting, display advertising can transform brand visibility and drive impressive ROI. Display advertising uses visually engaging ads, such as banners and videos, to promote a product or brand online. But how can pharma marketers harness its full potential?

Branding 52

Branding Marketing Doctors Doctor 52

World of DTC Marketing

DECEMBER 14, 2021

Third, the arguments that high costs are needed for continued innovation and that attempts to lower or regulate the prices will hamper innovation are not valid excuses. There is limited innovation when it comes to insulin; the more pressing need is affordability. The list price of insulin has increased between 300% to 500%.

Insulin 184

Insulin Branding Drugs Production 184

Pharmaceutical Technology

MAY 16, 2023

Lecanemab, the brand name of which is LEQEMBI in the US, is indicated to treat mild cognitive impairment caused due to AD and mild AD in people with confirmed presence of amyloid pathology in the brain. Health Canada has accepted a new drug submission (NDS) for Eisai and Biogen ’s lecanemabto to treat early Alzheimer’s disease (AD).

Antibody 130

Antibody FDA Approval Branding Regulation 130

BioPharma Reporter

JANUARY 13, 2022

Protagen, BioAnalytix, and GeneWerk this week announced their unified operations and re-brand as ProtaGene, a CRO partner for the biologics and cell and gene therapy developers, from discovery to commercialization.

Gene Therapy 126

Gene Therapy Branding Gene Development 126

Drug Patent Watch

JANUARY 29, 2025

Generic drug production involves replicating a brand-name medication's active ingredient, formulation, and dosage. Manufacturers must navigate a complex web of laws and regulations, including those related to patent protection, intellectual property, and safety standards. Let's start with the basics. Sounds straightforward, right?

Generic Drugs 73

Generic Drugs Production Compliance Drugs 73

Pharmaceutical Technology

JULY 26, 2022

Several drugs in the pipeline have novel mechanisms of action (MOAs), including novel calcium channel regulator acetylleucine and cyclodextrin therapies, adrabetadex and Trappsol Cyclo. This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market.

Marketing 306

Marketing Gene Branding Clinical Development 306

Cloudbyz

MARCH 3, 2023

Brand Awareness Mid-size CROs may lack the brand recognition that larger CROs possess. To address this challenge, mid-size CROs should invest in marketing and branding to increase their visibility and differentiate themselves from their competitors.

Compliance 98

Compliance Branding Packaging Packaging 98

Pharmaceutical Technology

DECEMBER 12, 2022

A targeted C3 therapy, Empaveli is a complement inhibitor which can regulate the complement cascade activity. In the EU and the UK, the therapy is approved as an orphan drug under the brand name Aspaveli to treat PNH patients who are anaemic following C5 inhibitor treatment for a minimum of three months. .

Clinical Trials 147

Clinical Trials Clinical Trials Branding Regulation 147